Sam Huang

Sam Huang Portfolio

Invests via Checkpoint Capital L.P. | Managed by Sam Huang
Invests via Checkpoint Capital L.P.
Managed by Sam Huang
Automatically Tracked
Tracking: 0 Updated: Jul 16 at 04:00 PM
Sam Huang Profile

Silicon Valley–connected investor and operator focused on growth-stage AI and enterprise SaaS markets. Sam Huang is an entrepreneur-turned-investor with operating experience scaling product and GTM teams across cloud software and developer tooling. He evaluates opportunities at the intersection of AI infrastructure and workflow automation, advising boards on go-to-market strategy, metrics-driven scaling and capital strategy. Prior roles span startup founding, early-stage investing, and corporate development; speaks to LPs and strategic acquirers.

Silicon Valley–connected investor and operator focused on growth-stage AI and enterprise SaaS markets. Sam Huang is an entrepreneur-turned-investor with operating experience scaling product and GTM teams across cloud software and developer tooling. He evaluates opportunities at the intersection of AI infrastructure and workflow automation, advising boards on go-to-market strategy, metrics-driven scaling and capital strategy. Prior roles span startup founding, early-stage investing, and corporate development; speaks to LPs and strategic acquirers.

Investment Philosophy & Strategy

Operator-investor approach focused on growth-stage AI and enterprise SaaS, prioritizing companies at the intersection of AI infrastructure and workflow automation. Thesis-driven capital allocation emphasizes metrics-led go-to-market scaling, unit-economics improvement and board-level operational support. Prefers conviction-sized, mid-to-long-term growth investments in cloud software and developer tooling, deploying capital to accelerate product-market fit, topline expansion and disciplined margin improvement.

Operator-investor approach focused on growth-stage AI and enterprise SaaS, prioritizing companies at the intersection of AI infrastructure and workflow automation. Thesis-driven capital allocation emphasizes metrics-led go-to-market scaling, unit-economics improvement and board-level operational support. Prefers conviction-sized, mid-to-long-term growth investments in cloud software and developer tooling, deploying capital to accelerate product-market fit, topline expansion and disciplined margin improvement.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
16.78%
Gain
Monthly
0.51%
Yearly
6.3%
Drawdown
55.25%
$354.35M
Equity
Holdings
$354.35M
Investment
$203.7M
$172.18M
Profit -$5.07M
Realized
$21.53M
Unrealized
$150.65M
Dividends
$0

Goals

Avg. 100% completed goals
Yearly
Gain > 5%
2026
100%
Yearly
Gain < 20%
2026
100%
Today
Compared To Yesterday
Gain
0%
Profit
-$5.07M
Win %
96%
This Week
Compared To Last Week
Gain
-1.97%
Profit
-$7.11M
Win %
96%
This Month
Compared to last month
Gain
-4.56%
Profit
-$16.91M
Win %
96%
This Year
Compared to last year
Gain
27.17%
Profit
$75.7M
Win %
88%
No Data
Trevi Therapeutics Inc. logo
TRVI Trevi Therapeutics Inc.
-4.27%
-$38,750
Revolution Medicines Inc. logo
RVMD Revolution Medicines Inc.
-2.59%
-$1.25M
Septarna Inc. logo
SEPN Septarna Inc.
-2.55%
-$87,261
Rhythm Pharmaceuticals Inc. logo
RYTM Rhythm Pharmaceuticals Inc.
-1.84%
-$2.48M
Cytokinetics, Incorporated logo
CYTK Cytokinetics, Incorporated
-1.75%
-$261,000
Disc Medicine Inc. logo
IRON Disc Medicine Inc.
-1.38%
-$300,994.05
argenx SE American Depositary Receipt logo
ARGX argenx SE American Depositary Receipt
-0.49%
-$653,310
Crinetics Pharmaceuticals Inc. logo
CRNX Crinetics Pharmaceuticals Inc.
-0.04%
-$1,408.05
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
125
Longs Won
76/125 60%
Profit Factor
4.54
Profitability
Shorts Won
0/0 0%
Standard Deviation
$4.78M
Average Win
$2.9M
Best Trade
(Jul 10) $33.16M
Sharpe Ratio
-21.15
Average Loss
-$991,259.06
Worst Trade
(Mar 30) -$13.08M
Z-Score
2.06 (96.04%)
Commissions
$0
Avg. Trade Length
8m 3w 6d
Expectancy
$1.38M
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.01% 1.14%
Consecutive Losing Trades 358 322 286 250 215 179 143 107 72 36
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV